2017
The experience sampling method as an mHealth tool to support self‐monitoring, self‐insight, and personalized health care in clinical practice
van Os J, Verhagen S, Marsman A, Peeters F, Bak M, Marcelis M, Drukker M, Reininghaus U, Jacobs N, Lataster T, Simons C, Investigators E, Lousberg R, Gülöksüz S, Leue C, Groot P, Viechtbauer W, Delespaul P. The experience sampling method as an mHealth tool to support self‐monitoring, self‐insight, and personalized health care in clinical practice. Depression And Anxiety 2017, 34: 481-493. PMID: 28544391, DOI: 10.1002/da.22647.Peer-Reviewed Original ResearchConceptsExperience sampling methodClinical practiceTrial of MindfulnessESM data collectionPersonalized trajectoriesEmotion dynamicsCognitive abilitiesRoutine clinical practiceDifferent patient groupsNatural rewardsRoutine outcome measurementDaily lifeBlended careMix of faceImplicit patternsMental healthSmartphone usePatient groupOffice treatmentTwin studiesOutcome measurementsProcess of diagnosisMHealth toolsTreatment evaluationDecision making
2013
Investigating the safety and efficacy of naltrexone for anti-psychotic induced weight gain in severe mental illness: study protocol of a double-blind, randomized, placebo-controlled trial
Tek C, Guloksuz S, Srihari VH, Reutenauer EL. Investigating the safety and efficacy of naltrexone for anti-psychotic induced weight gain in severe mental illness: study protocol of a double-blind, randomized, placebo-controlled trial. BMC Psychiatry 2013, 13: 176. PMID: 23805859, PMCID: PMC3702521, DOI: 10.1186/1471-244x-13-176.Peer-Reviewed Original ResearchConceptsSevere mental illnessEfficacy of naltrexoneWeight gainOutcome measurementsHealth problemsMental illnessGreater New Haven areaTumor necrosis factor alphaWeight lossCurrent available medicationsPlacebo-controlled trialHigh-sensitivity CRPOpioid receptor antagonistSecondary outcome measuresSerum lipid profilePrimary outcome measurementBody mass indexD2 receptor blockadeEffects of naltrexoneNovel pharmacological optionsNecrosis factor alphaDoses of naltrexoneMajor health problemRates of obesitySignificant weight loss